Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.355
-0.017 (-4.57%)
Nov 4, 2024, 4:00 PM EST - Market closed
Biomerica Market Cap
Biomerica has a market cap or net worth of $5.97 million as of November 4, 2024. Its market cap has decreased by -54.76% in one year.
Market Cap
5.97M
Enterprise Value
3.86M
1-Year Change
-54.76%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $5.97M, a decrease of -75.43%. That is a compound annual growth rate of -15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 6.30M | -70.00% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 6.64M |
| Universe Pharmaceuticals INC | 6.55M |
| Adial Pharmaceuticals | 6.47M |
| Xenetic Biosciences | 6.32M |
| Windtree Therapeutics | 6.31M |
| Forte Biosciences | 6.10M |
| Biofrontera | 6.04M |
| Hoth Therapeutics | 5.94M |